{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:30:13Z","timestamp":1770298213706,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"vor","delay-in-days":69,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Magnetic Resonance"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1186\/s12968-019-0528-5","type":"journal-article","created":{"date-parts":[[2019,3,10]],"date-time":"2019-03-10T20:02:27Z","timestamp":1552248147000},"page":"17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion"],"prefix":"10.1016","volume":"21","author":[{"given":"Puja","family":"Shahrouki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah N.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biraj","family":"Bista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen T.","family":"Kee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian G.","family":"DeRubertis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takegawa","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim-Lien","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Paul","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1186\/s12968-019-0528-5_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.seminhematol.2007.02.004","article-title":"Epidemiology and risk factors for venous thrombosis","volume":"44","author":"Cushman","year":"2007","journal-title":"Semin Hematol"},{"key":"10.1186\/s12968-019-0528-5_bib2","unstructured":"Diagnosis and treatment of central venous obstruction [http:\/\/www.vascularaccesssociety.com\/resources\/media\/Guidelines\/8_diagnosis_and_treatment_of_central_venous_obstruction.pdf]."},{"key":"10.1186\/s12968-019-0528-5_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1148\/radiology.187.1.8451422","article-title":"Central venous occlusion: MR angiography","volume":"187","author":"Finn","year":"1993","journal-title":"Radiology"},{"key":"10.1186\/s12968-019-0528-5_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2214\/AJR.06.1240","article-title":"CT pulmonary angiography and CT venography: factors associated with vessel enhancement","volume":"189","author":"Arakawa","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1186\/s12968-019-0528-5_bib5","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.2214\/ajr.178.6.1781465","article-title":"Pitfalls in CT venography of lower limbs and abdominal veins","volume":"178","author":"Ghaye","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1186\/s12968-019-0528-5_bib6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.crad.2007.09.010","article-title":"Diagnostic value of CT for deep vein thrombosis: results of a systematic review and meta-analysis","volume":"63","author":"Thomas","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1186\/s12968-019-0528-5_bib7","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMra072149","article-title":"Computed tomography\u2013an increasing source of radiation exposure","volume":"357","author":"Brenner","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1186\/s12968-019-0528-5_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/RLI.0b013e31816be927","article-title":"Noncontrast 3D steady state free precession magnetic resonance angiography of the thoracic central veins using nonselective radiofrequency excitation over a large field of view: initial experience","volume":"43","author":"Tomasian","year":"2008","journal-title":"Investig Radiol"},{"key":"10.1186\/s12968-019-0528-5_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.clinimag.2017.05.020","article-title":"Upper extremity non-contrast magnetic resonance venography (MRV) compared to contrast enhanced MRV and ultrasound","volume":"45","author":"Lim","year":"2017","journal-title":"Clin Imaging"},{"key":"10.1186\/s12968-019-0528-5_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmri.22789","article-title":"Non-contrast enhanced MR angiography: established techniques","volume":"35","author":"Miyazaki","year":"2012","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/s12968-019-0528-5_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejrad.2011.01.093","article-title":"Non-contrast-enhanced MR angiography of the abdomen","volume":"80","author":"Miyazaki","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1186\/s12968-019-0528-5_bib12","doi-asserted-by":"crossref","first-page":"625614","DOI":"10.1155\/2014\/625614","article-title":"A comparison between gadofosveset trisodium and gadobenate dimeglumine for steady state MRA of the thoracic vasculature","volume":"2014","author":"Camren","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1186\/s12968-019-0528-5_bib13","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/ndt\/gfk062","article-title":"Gadolinium\u2013a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?","volume":"21","author":"Grobner","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1186\/s12968-019-0528-5_bib14","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1681\/ASN.2006060601","article-title":"Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging","volume":"17","author":"Marckmann","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1186\/s12968-019-0528-5_bib15","unstructured":"Manual on Contrast Media v10.2 https:\/\/www.acr.org\/-\/media\/ACR\/Files\/Clinical-Resources\/Contrast_Media.pdf."},{"key":"10.1186\/s12968-019-0528-5_bib16","unstructured":"FDA Drug Safety Communication: New warnings for using gadolinium-based contrast agents in patients with kidney dysfunction https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm223966.htm."},{"key":"10.1186\/s12968-019-0528-5_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/RLI.0000000000000252","article-title":"Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with Normal renal function","volume":"51","author":"Murata","year":"2016","journal-title":"Investig Radiol"},{"key":"10.1186\/s12968-019-0528-5_bib18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2015150337","article-title":"Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent","volume":"275","author":"Radbruch","year":"2015","journal-title":"Radiology"},{"key":"10.1186\/s12968-019-0528-5_bib19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2215\/CJN.06840712","article-title":"The USRDS: what you need to know about what it can and can't tell us about ESRD","volume":"8","author":"Foley","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1186\/s12968-019-0528-5_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1525-139X.2007.00242.x","article-title":"Central vein stenosis: a nephrologist's perspective","volume":"20","author":"Agarwal","year":"2007","journal-title":"Semin Dial"},{"key":"10.1186\/s12968-019-0528-5_bib21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00270-012-0498-6","article-title":"Central venous disease in hemodialysis patients: an update","volume":"36","author":"Modabber","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1186\/s12968-019-0528-5_bib22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1525-139X.2008.00496.x","article-title":"Hemodialysis catheter-associated central venous stenosis","volume":"21","author":"Yevzlin","year":"2008","journal-title":"Semin Dial"},{"key":"10.1186\/s12968-019-0528-5_bib23","unstructured":"FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol) https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm440138.htm."},{"key":"10.1186\/s12968-019-0528-5_bib24","unstructured":"FERAHEME\u00ae (ferumoxytol injection), for intravenous use https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/022180s009lbl.pdf."},{"key":"10.1186\/s12968-019-0528-5_bib25","doi-asserted-by":"crossref","unstructured":"Toth GB, Varallyay CG, Horvath A, Bashir MR, Choyke PL, Daldrup-Link HE, Dosa E, Finn JP, Gahramanov S, Harisinghani M, et al. Current and potential imaging applications of ferumoxytol for magnetic resonance imaging. Kidney Int. 2017.","DOI":"10.1016\/j.kint.2016.12.037"},{"issue":"3","key":"10.1186\/s12968-019-0528-5_bib26","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/jmri.25580","article-title":"Ferumoxytol vs. gadolinium agents for contrast-enhanced MRI: thoughts on evolving indications, risks, and benefits","volume":"46","author":"Finn","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/s12968-019-0528-5_bib27","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.crad.2016.03.020","article-title":"Cardiovascular MRI with ferumoxytol","volume":"71","author":"Finn","year":"2016","journal-title":"Clin Radiol"},{"key":"10.1186\/s12968-019-0528-5_bib28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000087212","article-title":"Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients","volume":"25","author":"Landry","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1186\/s12968-019-0528-5_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1348\/000711006X126600","article-title":"Computing inter-rater reliability and its variance in the presence of high agreement","volume":"61","author":"Gwet","year":"2008","journal-title":"Br J Math Stat Psychol"},{"key":"10.1186\/s12968-019-0528-5_bib30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.RVI.0000079980.80153.4B","article-title":"Radiation doses in interventional radiology procedures: the RAD-IR study: part I: overall measures of dose","volume":"14","author":"Miller","year":"2003","journal-title":"J Vasc Interv Radiol"},{"key":"10.1186\/s12968-019-0528-5_bib31","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1148\/radiol.2382042070","article-title":"Radiation doses from venous access procedures","volume":"238","author":"Storm","year":"2006","journal-title":"Radiology"},{"key":"10.1186\/s12968-019-0528-5_bib32","doi-asserted-by":"crossref","unstructured":"Jonczyk M, Gebauer B, Schnapauff D, Rotzinger R, Hamm B, Collettini F. Peripherally inserted central catheters: dependency of radiation exposure from puncture site and level of training. Acta Radiol. 2017:284185117730101.","DOI":"10.1177\/0284185117730101"},{"key":"10.1186\/s12968-019-0528-5_bib33","doi-asserted-by":"crossref","first-page":"42K","DOI":"10.1016\/j.amjcard.2006.01.023","article-title":"Panel CINCW: Contrast medium use","volume":"98","author":"Davidson","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1186\/s12968-019-0528-5_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ajh.21656","article-title":"FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease","volume":"85","author":"Lu","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1186\/s12968-019-0528-5_bib35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/jmri.25412","article-title":"MRI with ferumoxytol: a single center experience of safety across the age spectrum","volume":"45","author":"Nguyen","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1186\/s12968-019-0528-5_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/RLI.0000000000000230","article-title":"Safety report of Ferumoxytol for magnetic resonance imaging in children and young adults","volume":"51","author":"Muehe","year":"2016","journal-title":"Investig Radiol"},{"key":"10.1186\/s12968-019-0528-5_bib37","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mri.2015.10.019","article-title":"Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adults","volume":"34","author":"Ning","year":"2016","journal-title":"Magn Reson Imaging"},{"key":"10.1186\/s12968-019-0528-5_bib38","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.3174\/ajnr.A5188","article-title":"What does the boxed warning tell us? Safe practice of using Ferumoxytol as an MRI contrast agent","volume":"38","author":"Varallyay","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1186\/s12968-019-0528-5_bib39","unstructured":"FeraSafe Registry. http:\/\/ferasafe.ucla.edu\/index.jsp."},{"key":"10.1186\/s12968-019-0528-5_bib40","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s00247-016-3605-z","article-title":"Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol","volume":"46","author":"Luhar","year":"2016","journal-title":"Pediatr Radiol"},{"key":"10.1186\/s12968-019-0528-5_bib41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00467-014-2953-x","article-title":"High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort","volume":"30","author":"Nayak","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1186\/s12968-019-0528-5_bib42","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00247-014-3226-3","article-title":"Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children","volume":"45","author":"Ruangwattanapaisarn","year":"2015","journal-title":"Pediatr Radiol"},{"key":"10.1186\/s12968-019-0528-5_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/jmri.24330","article-title":"Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases","volume":"40","author":"Bashir","year":"2014","journal-title":"J Magn Reson Imaging"}],"container-title":["Journal of Cardiovascular Magnetic Resonance"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12968-019-0528-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12968-019-0528-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664723001904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664723001904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12968-019-0528-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:58:15Z","timestamp":1761094695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097664723001904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1097664723001904"],"URL":"https:\/\/doi.org\/10.1186\/s12968-019-0528-5","relation":{},"ISSN":["1097-6647"],"issn-type":[{"value":"1097-6647","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Magnetic Resonance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s12968-019-0528-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 THE AUTHORS. Published by Elsevier Inc on behalf of the Society for Cardiovascular Magnetic Resonance","name":"copyright","label":"Copyright"}],"article-number":"17"}}